FCGR2A and inflammatory bowel disease: Studies by Tomas Castro-Dopico and Kouichi Asano revealed the gene’s significant association with UC susceptibility and its pronounced effect in females (44–46), emphasizing FCGR2A’s importance in IBD pathogenesis and its therapeutic potential.